title: Recent advances for the management of Raynaud phenomenon using botulinum neurotoxin A.
authors: Wake Forest University School of Medicine, Department of Orthopaedic Surgery, Medical Center Boulevard, Winston-Salem, NC 27157-1070, USA. smannava@wakehealth.edu
authors: Sandeep
authors: S
authors: Mannava
authors: Johannes F
authors: JF
authors: Plate
authors: Austin V
authors: AV
authors: Stone
authors: Thomas L
authors: TL
authors: Smith
authors: Beth P
authors: BP
authors: Smith
authors: L Andrew
authors: LA
authors: Koman
authors: Christopher J
authors: CJ
authors: Tuohy
mesh_terms: D019274:Botulinum Toxins, Type A / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D007267:Injections; D009465:Neuromuscular Agents / Q000008:administration & dosage*; D011928:Raynaud Disease / Q000628:therapy*
chemical_list: D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A